SWM
DAWN

SHP Wealth Management’s Day One Biopharmaceuticals DAWN Stock Holding History

SHP Wealth Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$536 Buy
+25
New +$352 ﹤0.01% 1607

Other funds holding DAWN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

SHP Wealth Management's DAWN Position: Q1 2026 in Review

SHP Wealth Management opened a new position in Day One Biopharmaceuticals (DAWN) in Q1 2026: 25 shares worth $536. The stake represents ﹤0.01% of the portfolio and ranks #1607 among its holdings.

207 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • SHP Wealth Management held 25 shares of Day One Biopharmaceuticals worth $536 as of Q1 2026.
  • Day One Biopharmaceuticals was a new SHP Wealth Management position in Q1 2026.
  • Day One Biopharmaceuticals made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #1607 holding.
  • 207 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.